Home > Professor (CV) > Bibliography (Books)

Professor

Bibliography (Books)

  1. Higaki J, Ogihara T, Nakamaru M, Mikami M, Morishita R, Kumahara Y. Hypothalamic-pituitary-adrenal axis in primary aldosteronism. In:The adrenal and hypertension: from cloning to clinic. Serono symposium publications 57,201-207, eds Mantero S, Takeda R, Scoggins BA, Opocher G, Raven Press, NY.
  2. Morishita R, Gibbons GH, Dzau VJ. Gene therapy as potential treatment for cardiovascular diseases. Cardiovascular Pharmacology And Therapeutics eds, Singh BN, p51-61, New Tork, Libingstone Publisher, 1993
  3. Yamada K, Moriguchi A, Mikami H, Higaki J, Morishita R, Aoki M, Okuda N, Ogihara T. Importance of central amino acid neurotransmitter in the hypotensive effect of angiotensin II type I receptor antagonist in the spontaneously hypertensive rat. Central Nervous System and Blood Pressure Control, edited by Niwa M, Imaizumi T and Takahashi H, Yubunsha, Tokyo, Japan, 1995, 65-70.
  4. Dzau VJ, Von Der Leyen HE, Morishita R. The concept and potentials of cardiovascular gene therapy. In: Dialogues in Cardiovascular Medicine; Gene Therapy 1997;2.1-3.
  5. Morishita R, Aoki M, Matsumoto H, Hayashi S, Nakamura S, Nakano N, Nishii T, Yamamoto K, Tomita N, Moriguchi A, Ogihara T. Functional analysis of tissue renin-angiotensin System using “gain and loss of function” approaches: in vivo test of in vitro hypothesis. in “Angiotensin II receptor blockade: physiological and clinical implications” edited by Dhalla NS, Zahradka P, Dixon IMC, Beamish RE. Kluwer Academic Publishers, Boston, 1997. (in press)
  6. Morishita R, Aoki M, Matsushita H, Kaneda Y, Higaki J, Ogihara T. Gene therapy for myocardial infarction. The Ischemic Heart edited by Mochizuki S, Takeda N, Nagano M, Dhalla NS. Kluwer Academic Publishers, Boston, 1998. 531-550.
  7. Morishita R, Aoki M, Nakamura S, Nakagami H, Taniyama Y, Yamamoto K, Moriguchi A, Higaki J, Ogihara T, Kaneda Y. Gene therapy for cardiovascular disease: is gene therapy a real medicine in next millennium? Proceeding of 3rd Green Cross International Symposium, Edited by Suzuki K, Ikeda Y, Maruyama I. Eibun Press Ltd., Osaka, 2000:217-229.
  8. Morishita R, Aoki M, Nakagami H, Taniyama Y, Yamamoto K, Matsushita H, Matsumoto K, Higaki J, Kaneda Y, Ogihara T. Gene therapy for myocardial infarction: a real medicine in next millenium ? Heart Failure; Frontiers in Cardiology, eds. Kitabatake A, Sasayama S, Francis G.S. 2000, Springer, Tokyo, 219-226
  9. Isobe M, Suzuki J, Morishita R, Kaneda Y, Amano J. Gene therapy for heart transplantation-associated coronary arteriosclerosis. Atherosclerosis V. The Fifth Saratoga International Conference. Edited by Numano F & Gimbrone MA. Ann New York Acad Sci 2000, 902: 77-83.
  10. Morishita R, Aoki M, Nakamura S, Higaki J, Kaneda Y, Ogihara T. Gene therapy for cardiovascular disease using hepatocyte growth factor. Atherosclerosis V. The Fifth Saratoga International Conference. Edited by Numano F & Gimbrone MA. Ann New York Acad Sci 2000, 902: 369-376.
  11. Kaneda Y, Nakasima H, Tsuboniwa N, Morishita R. Progress of fusigenic viral-liposomes. Progress in Gene Therapy: basic and clinical frontiers. edited by Bertolottis R et al. VSP, 2000:225-243.
  12. Morishita R, Aoki M, Kaneda Y. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease. Atherosclerosis VI. Edited by Bertolottis R et al. Numano F and MA Gimbrone. Annals of The New York Academy of Sciences. 2001;947:294-302
  13. Morishita R, Kaneda Y. HVJ-liposome method. “Methods in Enzymology” edited by M I Phillips. Academic Press. 2002, 619-627
  14. Morishita R. Cardiovascular disease: gene therapy. The Encyclopedia of the Human Genome, Nature Publishing Group. 2003(in press)
  15. Morishita R, Tomita N, Kaneda Y, Ogihara T. Potential of transcription factor decoy oligonucleotides as therapeutic approach. “Transcription Factor” in "Handbook of Experimental Pharmacology", edited by M. Gossen, S. Triezenberg and J. Kaufmann, the Springer-Verlag. 2004; 439-453
  16. Morishita R, Tomita N, Ogihara T. Decoy oligodeoxynucleotides as viable pharmaceutical drugs. “Synthetic nucleic acids as inhibitors of gene expression: mechanisms, application and therapeutic implications” edited by Dr. Levon Khachigian, Nova Science (Hauppauge, NY) 2004:161-175
  17. Morishita R. Gene therapy vs pharmacotherapy. “Contemporary Cardiology: Cardiovascular genomics” edited by Dr. M/K/ Raizada et al. Humana Press Inc., Totowa, NJ. 2005:137-156
  18. Morishita R. (January 2007) Cardiovascular Disease: Gene Therapy. In: ENCYCLOPEDIA OF LIFE SCIENCES. John Wiley & Sons, Ltd: Chichester
  19. Morishita R, Ogihara T. Hepatocyte Growth Factor. “Modern Concepts in Angiogenesis” edited by M Simons & GM Rubanyi. Imperial College Press 2007;367-384
  20. Tsukda Y, Tsujimoto H, Hara K, Huang CC, Sakaguchi M, Aoki M, Morishita R, Kawashima Y. Pharmacological study of NFkB decoy oligodeoxynucleotides loaded PLGA nanospheres. “The first asian symposium on pharmaceutical sciences and technology” P86-89, 2007
  21. Morishita R. Control of Cellular Physiology by E2F transcription factors. “E2F as therapeutic target using decoy strategy”. 2008;413-422. Edited By Kenichi Yoshida. Research Signpost, Kerala, India.
  22. Nakagami H, Osako MK, Morishita R. Gene therapy toward clinical application in the cardiovascular field. “Neurovascular Medicine: Pursuing cellular longevity for healthy aging” edited by Dr. Kenneth Maiese, Oxford University Press (NY) 2008:508-520
  23. Suzuki J, Isobe M, Morishita R, Nagai R. Gene Therapy for Prevention of Acute and Chronic Cardiac Rejection. In Heart Transplantation. Catherine T Fleming (eds) in the series of Cardiology Research and Clinical Developments. Nova Science Publishers Inc. 2009: 17-23.
  24. Suzuki J, Isobe M, Morishita R, Nagai R. Antioxidation in Prevention of Cardiovascular Disease-An Effect of Polyphenols. In Aging and Age-related Disorders. Bondy S (eds) in the series of Oxidative Stress in Applied Basic Research and Clinical Practice. Armstrong D (eds.) Springer/Humana press. CA, 2010: 297-307.
  25. Osako MK, Nakagami H, Morishita R. Development and Modification of Decoy Oligodeoxynucleotides Toward for Clinical Application. In Advances in Polymer Science. Springer-Verlag Berlin Heidelberg, 2012, 1-11, DOI: 10.1007/12_2011_139
  26. Iwabayashi M, Taniyama Y, Azuma J, Iekushi K, Rakugi H, Morishita R. Role of Serotonin in Angiogenesis in Diabetes. Biochemical Basis and Therapeutic Implications of Angiogenesis. Advance in Biochemistry in Health and Disease 6 edited by Jawahar L Mehta & Naranjan S Dhalla. Springer NY. 2013:225-238
  27. Koriyama H, Nakagami H, Katsuya T, Morishita R. Functions of OSBP/ORP family proteins and their relation to dyslipidemia. Chapter in Dyslipidemia (in press)
  28. Sato N, Morishita R. Aβ Deposition, Insulin Signaling and Tau Phosphorylation in Animal Models for Alzheimer Disease and Diabetes. “Metabolic Syndrome and Neurological Disorders,” edited by Tahira Farooqui and Akhlaq Farooqui. 2013 (in press)
[Professor: Ryuichi Morishita]
Page Top